Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics.
Krueger
Karl E
KE
Cancer Biomarkers Research Group, Division of Cancer Prevention, NCI, National Institutes of Health, Bethesda, Maryland 20892-7362, USA.
Srivastava
Sudhir
S
D014408:Biomarkers, Tumor / Q000378:metabolism; D002843:Chromatin / Q000737:chemistry; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis* / Q000517:prevention & control / Q000628:therapy*; D009687:Nuclear Proteins / Q000378:metabolism*; D011499:Protein Processing, Post-Translational; D015398:Signal Transduction
D014408:Biomarkers, Tumor; D002843:Chromatin; D009687:Nuclear Proteins